[Relationship between high-sensitivity C-reactive protein and obesity/metabolic syndrome in children]

Fangfang Chen1, Wenpeng Wang1, Yue Teng2

  • 1Department of Epidemiology, Capital Institute of Pediatrics, Beijing 100020, China.

Insights

High-sensitivity C-reactive protein (hsCRP) is linked to childhood obesity and metabolic syndrome factors. Obesity, particularly waist circumference, is the strongest independent predictor of hsCRP levels in children.

Area of Science:

  • Pediatric Endocrinology
  • Cardiovascular Health
  • Metabolic Disorders

Background:

  • Childhood obesity and metabolic syndrome (MetS) are growing public health concerns.
  • High-sensitivity C-reactive protein (hsCRP) is a marker of inflammation associated with cardiovascular risk.
  • Understanding the relationship between hsCRP and MetS components in children is crucial for early intervention.

Purpose of the Study:

  • To investigate the association between hsCRP and various obesity and MetS-related factors in a cohort of Chinese children.
  • To identify the primary drivers of elevated hsCRP in this pediatric population.

Main Methods:

  • A cross-sectional study involving 403 children aged 10-14 years from Beijing.
  • Measurements included anthropometrics (height, weight, waist circumference, fat mass percentage), blood pressure, and biochemical markers (hsCRP, lipids, glucose).
  • Statistical analyses included partial correlation, ANCOVA, and linear regression, with hsCRP log-transformed (lgCRP) and MetS defined by IDF criteria.

Main Results:

  • Log-transformed hsCRP (lgCRP) showed positive correlations with BMI, waist circumference, fat mass percentage, blood pressure, fasting plasma glucose, LDL-C, and TC, and a negative correlation with HDL-C.
  • These associations, particularly with blood pressure and triglycerides, diminished after controlling for BMI, though a link with LDL-C persisted.
  • Linear regression identified waist circumference, BMI, and fat mass percentage as the strongest predictors of hsCRP, with obesity being the most significant independent factor.

Conclusions:

  • hsCRP is significantly associated with obesity, lipid profiles, and metabolic syndrome components in children.
  • Waist circumference and overall obesity are the most influential factors associated with hsCRP levels.
  • Obesity emerges as a key independent determinant of elevated hsCRP in pediatric populations, highlighting the importance of weight management.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
321
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
434
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
4.4K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
750
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K